Table 3.
Cost-Effectiveness Measure | FOBT (US$) | Flexible Sigmoidoscopy (US$) | Colonoscopy (US$) |
---|---|---|---|
Increase in screening rates, % | Screening rates did not increase | Screening rates did not increase | 7% |
Total cost of intervention | 147,865 | 147,865 | 147,865 |
ICER per percentage point increase in screening | * | * | 21,124 |
Sensitivity estimate, % (±10%) | * | * | 19,011-23,236 |
Total initial development costs | 42,968 | 42,968 | 42,968 |
Total intervention delivery costs (4 physicians per office) | 104,897 | 104,897 | 104,897 |
Sensitivity estimate (intervention delivery costs: 8 physicians per office 2×) | 52,449 | 52,449 | 52,449 |
Sensitivity estimate (intervention delivery costs: 2 physicians per office 1/2×) | 209,794 | 209,794 | 209,794 |
ICER sensitivity estimate | * | * | 13,631-36,109 |
Abbreviations: ICERs, incremental cost-effectiveness ratios; FOBT, fecal occult blood test.
ICER cannot be calculated because the intervention is not clinically effective.